Home › NDC Lookup › RxCUI directory › RxCUI 996824

Methylergonovine maleate 0.2 MG Oral Tablet — RxCUI 996824

RxNorm drug concept · Semantic clinical drug
RxCUI 996824 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI996824
Official nameMethylergonovine maleate 0.2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped16
Reported Medicaid activity (SDUD)3,922 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylergonovine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a medication given right after childbirth to help your uterus contract firmly and stop or prevent heavy bleeding. Sometimes the uterus doesn't tighten up on its own the way it...
  • What exactly is methylergonovine used for?
  • You'll typically take the tablet three or four times a day for up to one week after delivery, as your provider directs. One thing worth knowing: if you're taking it continuously in...
  • How should I take the tablet form, and is there anything I should know about timing?
📖 Read our full Methylergonovine guide →

🕸️ Concept Web — How Methylergonovine maleate 0.2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methylergonovine maleate 0.2 MG Oral Tablet RxCUI 996824

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Methylergonovine 6883
    • Methylergonovine maleate 84158
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Methergine 227555
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylergonovine Oral Tablet 372859
    • Methylergonovine maleate Oral Tablet 2646335
    • Methylergonovine Oral Product 1162887
    • Methylergonovine Pill 1162888
    • Methylergonovine maleate Oral Product 2663300
    • Methylergonovine maleate Pill 2661754
    • Methylergonovine Oral Tablet [Methergine] 368779
    • Methylergonovine maleate Oral Tablet [Methergine] 2656839
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methylergonovine maleate 0.2 MG SCDC · 996823
  • Methylergonovine Oral Tablet SCDF · 372859
  • Methylergonovine maleate Oral Tablet SCDFP · 2646335
  • Methylergonovine Oral Product SCDG · 1162887
  • Methylergonovine Pill SCDG · 1162888
  • Methylergonovine maleate Oral Product SCDGP · 2663300
  • Methylergonovine maleate Pill SCDGP · 2661754

Brand-Name Concepts

  • Methylergonovine maleate 0.2 MG Oral Tablet [Methergine] SBD · 996826
  • Methylergonovine maleate 0.2 MG [Methergine] SBDC · 996825
  • Methylergonovine Oral Tablet [Methergine] SBDF · 368779
  • Methylergonovine maleate Oral Tablet [Methergine] SBDFP · 2656839
  • Methergine Oral Product SBDG · 1176928
  • Methergine Pill SBDG · 1176929
  • Methergine BN · 227555

📦 FDA Products & Package NDCs

8 products · 16 package NDCs
16 package NDCs map to RxCUI 996824 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-3655-22 12 TABLET in 1 BOTTLE (0093-3655-22) Methylergonovine Maleate Teva Pharmaceuticals USA, Inc. 2019-03-26
00093-3655-28 28 TABLET in 1 BOTTLE (0093-3655-28) Methylergonovine Maleate Teva Pharmaceuticals USA, Inc. 2019-03-26
00904-7282-10 20 BLISTER PACK in 1 CARTON (0904-7282-10) / 1 TABLET in 1... Methylergonovine Maleate Major Pharmaceuticals 2024-09-13
16571-0735-01 100 TABLET in 1 BOTTLE (16571-735-01) Methylergonovine Maleate Rising Pharma Holdings, Inc. 2021-01-15
16571-0735-17 7 TABLET in 1 BOTTLE (16571-735-17) Methylergonovine Maleate Rising Pharma Holdings, Inc. 2021-01-15
16571-0735-21 12 TABLET in 1 BOTTLE (16571-735-21) Methylergonovine Maleate Rising Pharma Holdings, Inc. 2021-01-15
16571-0735-28 28 TABLET in 1 BOTTLE (16571-735-28) Methylergonovine Maleate Rising Pharma Holdings, Inc. 2021-01-15
27437-0050-56 28 TABLET in 1 BOTTLE (27437-050-56) Methergine Lupin Pharmaceuticals,Inc. 2016-04-04
27437-0050-57 12 TABLET in 1 BOTTLE (27437-050-57) Methergine Lupin Pharmaceuticals,Inc. 2016-04-04
60687-0813-94 20 BLISTER PACK in 1 CARTON (60687-813-94) / 1 TABLET in 1... Methylergonovine Maleate American Health Packaging 2024-02-15
69238-1605-02 12 TABLET in 1 BOTTLE (69238-1605-2) Methylergonovine Maleate Amneal Pharmaceuticals NY LLC 2018-09-12
69238-1605-08 28 TABLET in 1 BOTTLE (69238-1605-8) Methylergonovine Maleate Amneal Pharmaceuticals NY LLC 2018-09-12
70010-0786-12 12 TABLET in 1 BOTTLE (70010-786-12) Methylergonovine Maleate Granules Pharmaceuticals Inc. 2023-08-01
70010-0786-28 28 TABLET in 1 BOTTLE (70010-786-28) Methylergonovine Maleate Granules Pharmaceuticals Inc. 2023-08-01
83400-0100-12 12 TABLET in 1 BOTTLE (83400-100-12) Methylergonovine Maleate Volley Pharmaceuticals, LLC 2024-03-15
83400-0100-28 28 TABLET in 1 BOTTLE (83400-100-28) Methylergonovine Maleate Volley Pharmaceuticals, LLC 2024-03-15
Observed labelers: Rising Pharma Holdings, Inc. (4) · Amneal Pharmaceuticals NY LLC (2) · Granules Pharmaceuticals Inc. (2) · Lupin Pharmaceuticals,Inc. (2) · Teva Pharmaceuticals USA, Inc. (2) · Volley Pharmaceuticals, LLC (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$5.0102
Range $5.0102–$5.0102 · middle 50% $5.0102–$5.0102 · 10 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.